BCM
PFE icon

Brooktree Capital Management’s Pfizer PFE Stock Holding History

Brooktree Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Sell
101,435
-19,075
-16% -$508K 2.26% 13
2025
Q4 		$3M Sell
120,510
-9,136
-7% -$230K 2% 11
2025
Q3 		$3.3M Buy
129,646
+8,291
+7% +$205K 2.1% 12
2025
Q2 		$2.94M Buy
121,355
+3,184
+3% +$74.3K 1.92% 12
2025
Q1 		$2.99M Buy
118,171
+2,788
+2% +$73K 2.25% 11
2024
Q4 		$3.06M Buy
115,383
+1,389
+1% +$37.7K 2.27% 12
2024
Q3 		$3.3M Buy
113,994
+1,316
+1% +$38.4K 2.68% 12
2024
Q2 		$3.15M Sell
112,678
-8,574
-7% -$236K 2.7% 12
2024
Q1 		$3.36M Buy
121,252
+6,117
+5% +$170K 2.6% 14
2023
Q4 		$3.31M Sell
115,135
-9,877
-8% -$299K 2.68% 15
2023
Q3 		$4.15M Buy
125,012
+3,640
+3% +$129K 3.46% 13
2023
Q2 		$4.45M Sell
121,372
-4,228
-3% -$165K 3.38% 12
2023
Q1 		$5.12M Sell
125,600
-1,659
-1% -$71.7K 3.99% 12
2022
Q4 		$6.52M Sell
127,259
-2,557
-2% -$123K 5.36% 8
2022
Q3 		$5.68M Buy
129,816
+5,650
+5% +$275K 4.68% 8
2022
Q2 		$6.51M Buy
124,166
+2,621
+2% +$134K 4.89% 9
2022
Q1 		$6.29M Buy
121,545
+8,432
+7% +$438K 4.1% 9
2021
Q4 		$6.68M Sell
113,113
-1,206
-1% -$59.8K 4.08% 9
2021
Q3 		$4.92M Buy
114,319
+2,302
+2% +$102K 3.13% 12
2021
Q2 		$4.39M Buy
112,017
+17,348
+18% +$675K 2.82% 12
2021
Q1 		$3.43M Buy
94,669
+1,965
+2% +$69.8K 2.3% 16
2020
Q4 		$3.41M Sell
92,704
-6,109
-6% -$224K 2.51% 12
2020
Q3 		$3.44M Buy
98,813
+4,389
+5% +$154K 2.91% 11
2020
Q2 		$2.93M Buy
94,424
+1,657
+2% +$56.3K 2.75% 13
2020
Q1 		$2.87M Buy
92,767
+16,725
+22% +$570K 3.33% 11
2019
Q4 		$2.83M Buy
+76,042
New +$2.71M 2.59% 17

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Brooktree Capital Management's PFE Position: Q1 2026 in Review

Brooktree Capital Management reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $508K and leaving 101,435 shares worth $2.85M. The position accounts for 2.26% of the portfolio, ranked #13.

Brooktree Capital Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.68M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Brooktree Capital Management held 101,435 shares of Pfizer worth $2.85M as of Q1 2026.
  • Brooktree Capital Management sold 19,075 Pfizer shares in Q1 2026, an estimated $508K.
  • Pfizer made up 2.26% of Brooktree Capital Management's portfolio in Q1 2026, its #13 holding.
  • Brooktree Capital Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Brooktree Capital Management's Pfizer position peaked at $6.68M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brooktree Capital Management's 13F filing for Q1 2026, filed 6 May 2026.